Home / Inspections / 1122499

FDA Inspection 1122499 — Zydus Pharmaceuticals (USA) Inc

Zydus Pharmaceuticals (USA) Inc — FEI 3008444937

The FDA completed an inspection of Zydus Pharmaceuticals (USA) Inc on February 27, 2020 in Pennington, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 27, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pennington, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 878016 (NAI Thu May 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 710971 (VAI Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 666881 (NAI Mon Jun 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 605085 (NAI Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources